. 2014 Jul 21;60(5):377–382. doi: 10.1262/jrd.2014-062

Table 1. Development of cloned embryos treated with 5-aza-dC or TSA.

Groups	No. embryos (Rep.)	No. embryos cleaved (% ± SEM)	No. blastocysts (% ± SEM)	Blastocyst cell numbers (mean ± SEM) ^&
NT-CON	242 (5)	209 (85.79 ± 0.95)^a	50 (20.50 ± 0.70)^a	37 ± 3 (n=49)
NT-AZA	247 (5)	223 (89.88 ± 1.14)^b	67 (27.30 ± 1.24)^b	37 ± 2 (n=55)
NT-TSA	238 (5)	210 (88.82 ± 1.12)^ab	118 (50.71 ± 2.21)^c	38 ± 2 (n=76)

^& Blastocyst cell numbers of less than 16 or blastocysts used for molecular analysis (10 or 40 blastocysts in the NT-AZA or NT-TSA group, respectively) were not included. ^a–c Values in the same column with different superscripts differ significantly (P < 0.05).